The purpose of this study was to evaluate CD56 expression in DLBCL in our series, to estimate its relationship to epidemiological factors, to roughly estimate its value as a prognostic marker, and to describe, for the first time the molecular findings in a subset of cases. Here, NCAM1 is linked to diffuse large B-cell lymphoma.